[BMY] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[BMY] Bristol-Myers Squibb Company
Announcement Date
13-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -8.61%
YoY- -12.86%
Quarter Report
BMY's Result
BMY's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 11,477,000 11,406,000 11,985,000 11,068,000 7,945,000 5,973,000 5,449,000 13.21%
PBT 1,674,000 1,859,000 1,858,000 -10,451,000 -129,000 1,547,000 698,000 15.68%
Tax -88,000 -166,000 -514,000 -424,000 931,000 357,000 3,027,000 -
NP 1,762,000 2,022,000 2,372,000 -10,027,000 -1,056,000 1,192,000 -2,328,000 -
Tax Rate 5.26% 8.93% 27.66% - - -23.08% -433.67% -
Total Cost 9,715,000 9,384,000 9,613,000 21,095,000 9,001,000 4,781,000 7,777,000 3.77%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 15.35 17.73 19.79 -90.59 -13.29 19.96 -42.72 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 0.87 0.96 1.10 -4.45 -0.55 0.73 -1.42 -
EPS Diluted 0.87 0.95 1.07 -4.45 -0.55 0.73 -1.42 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.